|
Volumn 47, Issue 4, 2008, Pages 697-700
|
Predicting drug-resistant mutations of HIV protease
|
Author keywords
Drug design; Drug resistance; HIV protease; Ligand binding; Transition states
|
Indexed keywords
CATALYST ACTIVITY;
DRUG THERAPY;
ENZYME INHIBITION;
LIGANDS;
PROTEINS;
DRUG DESIGN;
DRUG RESISTANCE;
HUMAN IMMUNODEFICIENCY VIRUS (HIV);
LIGAND BINDING;
TRANSITION STATES;
VIRUSES;
4,7 DIBENZYL 2,3,4,5,6,7 HEXAHYDRO 5,6 DIHYDROXY 1,3 BIS[4 (HYDROXYMETHYL)BENZYL] 2H 1,3 DIAZEPIN 2 ONE;
DRUG DERIVATIVE;
PROTEINASE;
PROTEINASE INHIBITOR;
UREA;
ANTIVIRAL RESISTANCE;
ARTICLE;
BINDING SITE;
CATALYSIS;
CHEMICAL MODEL;
CHEMICAL STRUCTURE;
CHEMISTRY;
COMPUTER SIMULATION;
DRUG EFFECT;
ELECTRICITY;
GENETICS;
MUTATION;
STRUCTURE ACTIVITY RELATION;
THERMODYNAMICS;
BINDING SITES;
CATALYSIS;
COMPUTER SIMULATION;
DRUG RESISTANCE, VIRAL;
ELECTROSTATICS;
HIV PROTEASE;
HIV PROTEASE INHIBITORS;
MODELS, CHEMICAL;
MOLECULAR STRUCTURE;
MUTATION;
STRUCTURE-ACTIVITY RELATIONSHIP;
THERMODYNAMICS;
UREA;
|
EID: 38349001243
PISSN: 14337851
EISSN: None
Source Type: Journal
DOI: 10.1002/anie.200704178 Document Type: Article |
Times cited : (32)
|
References (16)
|